IC
ONC

IEQ Capital’s BeOne Medicines Ltd ONC Stock Holding History

IEQ Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
1,279
+465
+57% +$137K ﹤0.01% 1550
2026
Q1 		$242K Buy
814
+25
+3% +$8.09K ﹤0.01% 1612
2025
Q4 		$240K Buy
789
+21
+3% +$6.87K ﹤0.01% 1629
2025
Q3 		$262K Buy
+768
New +$233K ﹤0.01% 1573

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IEQ Capital's ONC Position: Q2 2026 in Review

IEQ Capital increased its BeOne Medicines Ltd (ONC) stake by 57% in Q2 2026, buying an estimated $137K and bringing the position to 1,279 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

IEQ Capital first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • IEQ Capital held 1,279 shares of BeOne Medicines Ltd worth $364K as of Q2 2026.
  • IEQ Capital bought 465 BeOne Medicines Ltd shares in Q2 2026, an estimated $137K.
  • BeOne Medicines Ltd made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1550 holding.
  • IEQ Capital first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.